| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |